A. Jørgensen

发表

A Longitudinal Follow-up of Autoimmune Polyendocrine Syndrome Type 1

J. Svartberg, P. Knappskog, E. Husebye, 2016, The Journal of clinical endocrinology and metabolism.

Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial.

J. Hallén, H. Fagertun, O. Gudmundsen, 2005, European journal of endocrinology.

Glucose homeostasis in adults with Prader-Willi syndrome during treatment with growth hormone: results from a 12-month prospective study.

J. Bollerslev, T. Ueland, J. Christiansen, 2014, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Two years of growth hormone treatment in adults with Prader-Willi syndrome do not improve the low BMD.

J. Bollerslev, T. Ueland, J. Christiansen, 2013, The Journal of clinical endocrinology and metabolism.

Residual Corticosteroid Production in Autoimmune Addison Disease

P. Dahlqvist, G. Grimnes, E. Husebye, 2020, The Journal of clinical endocrinology and metabolism.

Dual-energy X-ray absorptiometry is a valid method to estimate visceral adipose tissue in adult patients with Prader-Willi syndrome during treatment with growth hormone.

K. Godang, J. Bollerslev, A. Jurik, 2014, The Journal of clinical endocrinology and metabolism.

Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult‐onset growth hormone deficiency

K. Godang, J. Bollerslev, T. Ueland, 2011, Clinical endocrinology.

Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency.

J. Bollerslev, T. Ueland, T. Schreiner, 2006, European journal of endocrinology.

Increased serum and bone matrix levels of the secreted Wnt antagonist DKK-1 in patients with growth hormone deficiency in response to growth hormone treatment.

K. Godang, J. Bollerslev, T. Lekva, 2015, The Journal of clinical endocrinology and metabolism.

Clues for early detection of autoimmune Addison's disease – myths and realities

P. Dahlqvist, J. Svartberg, E. Husebye, 2018, Journal of internal medicine.

TGFBR3L—An Uncharacterised Pituitary Specific Membrane Protein Detected in the Gonadotroph Cells in Non-Neoplastic and Tumour Tissue

C. Lindskog, E. Sjöstedt, Åsa Sivertsson, 2020, Cancers.

Increased serum and bone matrix levels of transforming growth factor {beta}1 in patients with GH deficiency in response to GH treatment.

J. Bollerslev, T. Lekva, T. Ueland, 2011, European journal of endocrinology.

Cut-off values for sufficient cortisol response to low dose Short Synacthen Test after surgery for non-functioning pituitary adenoma

J. Bollerslev, A. Jørgensen, J. Pahnke, 2020, Acta Neurochirurgica.

Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency.

O. Gudmundsen, J. Bollerslev, T. Ueland, 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

The endocrine workup for primary aldosteronism should include adrenal venous sampling also in the young patients.

A. Jørgensen, 2021, The Journal of clinical endocrinology and metabolism.

FSH Levels Are Related to E-cadherin Expression and Subcellular Location in Nonfunctioning Pituitary Tumors

J. Bollerslev, A. Jørgensen, G. Ringstad, 2020, The Journal of clinical endocrinology and metabolism.

Bone: Growth hormone replacement—implications for bone health

J. Bollerslev, A. Jørgensen, 2012, Nature Reviews Endocrinology.

GWAS for autoimmune Addison’s disease identifies multiple risk loci and highlights AIRE in disease susceptibility

Lars Peter Jensen, P. Dahlqvist, T. Olsson, 2021, Nature Communications.

Effects of Growth Hormone Treatment on Sleep-Related Parameters in Adults With Prader-Willi Syndrome

L. Hussain-Alkhateeb, A. Jørgensen, C. Høybye, 2021, The Journal of clinical endocrinology and metabolism.

TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours

E. Sjöstedt, J. Bollerslev, A. Jørgensen, 2023, Pituitary.

Changing basal insulin from NPH to detemir or glargine in patients with type 1 diabetes and a history of severe hypoglycemia

O. Johansen, B. Kilhovd, A. Jørgensen, 2008, Vascular health and risk management.

Bone resorption following weight loss surgery is associated with treatment procedure and changes in secreted Wnt antagonists

K. Godang, J. Hjelmesæth, J. Bollerslev, 2016, Endocrine.

A polygenic risk score to help discriminate primary adrenal insufficiency of different etiologies

A. Lindstrand, S. Johansson, E. C. Røyrvik, 2023, Journal of internal medicine.

Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies

R. Cox, A. Meager, Fan Zhou, 2023, iScience.

A woman in her 50s with chronic fatigue syndrome, sepsis and hyponatraemia.

T. Meling, A. Jørgensen, Ø. K. Jørstad, 2017, Tidsskrift for Den Norske Laegeforening.

Vaccination prevents severe COVID-19 outcome in patients with neutralizing type 1 interferon autoantibodies

R. Cox, A. Meager, Fan Zhou, 2023, iScience.